[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Contact ::
:: Volume 22, Issue 6 (3-2021) ::
2021, 22(6): 499-505 Back to browse issues page
Evaluating Diagnostic Value of CD10 Marker in Differentiating Papillary Thyroid Carcinoma From Benign Thyroidal Lesions
Mohammad Ranaei , Soraya Khafry , Ali Ashkan Shahipour
Pathology Department, Clinical Research Development Unit of Rouhani Hospital, Medical School, Babol University of Medical Sciences, , shahipour@gmail.com
Abstract:   (194 Views)
Introduction: Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy. The present study aimed to determine the diagnostic value of the CD10 marker in differentiating PTC from its benign mimicries (i.e. different types of goiter). Materials and Methods: In this cross-sectional study, the paraffin-embedded blocks of 70 patients referred to Rouhani Hospital in Babol with a thyroid nodule based on pathologic report and review were divided into two groups, including 35 benign and 35 malignant lesions. The participants’ demographic information (namely age and gender) and ultrasound results (size and number of nodules) were recorded in the study checklist. Thyroid paraffin-embedded blocks and stained slides of all patients were collected from the archive and, after reviewing the slides, they were examined immunohistochemically for the CD10 marker. Results: We evaluated 70 patients in both benign and malignant groups and assessed the status of the CD10 marker. The mean age was 49.3±9.08 years in the benign group and 45.6±16.1 years in the malignant group. Regarding the participants’ gender, in each group, nine patients were male, and 26 patients were female. Classic PTC was noticed in 26 patients and there were the follicular variants of PTC in nine patients. The CD10 positivity was significantly correlated with several nodules (p=0.030), whereas the nodule size and CD10 positivity were not significantly different between the two groups (p=0.310). The diagnostic value of the CD10 marker in differentiating PTC and benign thyroid lesions was not significantly correlated in terms of nodule size (p=0.310), and there was a statistically significant relationship between age (p=0.005) and gender (p=0.03) with the number of nodules (p=0.030). Conclusion: According to the study results, the diagnostic value of the CD10 marker in differentiating papillary thyroid carcinoma from the goiter subtypes is statistically significant.
Keywords: Diagnosis, Antigen, CD10, Papillary thyroid carcinoma, Goiter
Full-Text [PDF 2322 kb]   (84 Downloads)    
Type of Study: Original | Subject: Endocrinology
Received: 2021/01/11 | Accepted: 2021/09/11 | Published: 2021/03/17
Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ranaei M, Khafry S, Shahipour A A. Evaluating Diagnostic Value of CD10 Marker in Differentiating Papillary Thyroid Carcinoma From Benign Thyroidal Lesions. Iranian Journal of Endocrinology and Metabolism. 2021; 22 (6) :499-505
URL: http://ijem.sbmu.ac.ir/article-1-2819-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 22, Issue 6 (3-2021) Back to browse issues page
مجله ی غدد درون‌ریز و متابولیسم ایران، دو ماهنامه  پژوهشی مرکز تحقیقات غدد درون‌ریز و متابولیسم، Iranian Journal of Endocrinology and Metabolism
Persian site map - English site map - Created in 0.04 seconds with 31 queries by YEKTAWEB 4353